Development of gemcitabine-adsorbed magnetic gelatin nanoparticles for targeted drug delivery in lung cancer

References

• Arya G, Vandana M, Acharya S, Sahoo SK. 2011. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine. 7:859–870.
   PubMed Web of Science ®Google Scholar
• Barbara S, Arpicco S, Rocco F, Marsaud V, Renoir JM. 2007. Encapsulation of gemcitabine into lipophilic derivatives polycyanoacrylate nanospheres and nanocapsules. Int J Pharm. 344:71–77.
   PubMed Web of Science ®Google Scholar
• Chen H, Langer R. 1998. Oral particulate delivery: status and future trends. Adv Drug Deliv Rev. 34:339–350.
   PubMed Web of Science ®Google Scholar
• Chien YW. 1992. Oral drug delivery and delivery systems. In: Y. W. Chien, Eds. Novel Drug Delivery Systems New York: Marcel Dekker Inc, pp. 139–196.
   Google Scholar
• Delie F. 1998. Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv Drug Deliv Rev. 34:221–233.
   PubMed Web of Science ®Google Scholar
• Ding D, Zhu Z, Qin L , Jing W , Yong H , Xiqun J, Baorui L. 2011. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: Synthesis, antitumor efficiency in vivo and penetration in tumors Eur J Pharm Biopharm. 79:142–149.
   PubMed Web of Science ®Google Scholar
• Dung DKT, Hai TH, Phuc LH, Long DB, LKVinh, Truc PN. 2009. Preparation and characterization of magnetic nanoparticles with chitosan coating. J Phys Conf Ser. 187:1–5.
   Google Scholar
• Gabr Y, Assem N, Michael A, Fahmy L. 1996. Evaluation studies on oxypolygelatin and degraded gelatin as plasma volume expander Arzneimittelforschung. 46:763–766.
   PubMed Web of Science ®Google Scholar
• Gaihre B, Aryal S, Barakat NAM, Kim HY. 2008. Gelatin stabilized iron oxide nanoparticles as a three dimensional template for the hydroxyapatite crystal nucleation and growth. Mater Sci Eng C. 28 :1297–1303.
   Web of Science ®Google Scholar
• Gaihre B, Aryal S, Khil MS, Kim HY. 2008. Encapsulation of Fe3O4 in gelatin nanoparticles: Effect of different parameters on size and stability of the colloidal dispersion. J. Microencapsul. 25:21–30.
   PubMed Web of Science ®Google Scholar
• Gaihre B, Khil MS, Lee DR, Kim HY. 2009. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study. Int. J. Pharm. 365:180–189.
   PubMed Web of Science ®Google Scholar
• Gennaro AR. 2006. Remington: The Science and Practice of Pharmacy. Part 5: Pharmaceutical Manufacturing/Extended-Release and Targeted Drug Delivery Systems, The New Drug Approval Process and Clinical Trial Design. In: Philadelphia, PA: Lippincott Williams Wilkins, pp. 939–965.
   Google Scholar
• Gomez-Guillen MC, Gimenez B, Lopez-Cabellero ME, Montero MP. 2011. Functional and bioactive properties of collagen and gelatin from alternative sources: a review. Food Hydrocolloids. 25(8):1813–1827.
   Web of Science ®Google Scholar
• Haley B, Frenkel E. 2008. Nanoparticles for drug delivery in cancer treatment. Urol Oncol. 26:57–64.
   PubMed Web of Science ®Google Scholar
• Hamarat Sanlier S, Ak G, Yilmaz H, Ozbakir G, Cagliyan O 2013. Removal of textile dye, direct red 23, with glutaraldehyde cross-linked magnetic chitosan beads. Prep Biochem Biotechnol. 43:163–176.
   PubMed Web of Science ®Google Scholar
• Hodge LS, Taub ME, Tracy TS. 2011. Effect of its deaminated metabolite, 2′,2′-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cells. Biochem. Pharmacol. 81:950–956.
   PubMed Web of Science ®Google Scholar
• Jongjareonrak A, Rawdkuen S, Chaijan M, Benjakul S, Osako K, M, Tanaka. 2010. Chemical compositions and characterisation of skin gelatin from farmed giant catfish (Pangasianodon gigas). LWT - Food Science and Technology. 43:161–165.
   Web of Science ®Google Scholar
• Kalevi K, Paola E, Kim B, Ernest KJP. 2008. Nanoparticles in cancer. Curr Radiopharm. 1:30–36.
   Google Scholar
• Leo E, Vandelli MA, Cameroni R, Forni F. 1997. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process. Int J Pharm. 155:75–82.
   Web of Science ®Google Scholar
• Lippincort R. 1997. American Joint Commitee on Cancer (AJCC), In: Cancer Staging Manual, 5th edn. , Lippincott Williams & Wilkins: Philadelphia, pp. 127–37.
   Google Scholar
• Lubbe AS, Alexiou C, Bergemann C 2001. Clinical applications of magnetic drug targeting J Surg Res. 95:200–206.
   PubMed Web of Science ®Google Scholar
• Martín-Banderas L, Sáez-Fernández E, Holgado A, Durán-Lobato M, Prados JC, Melguizo C, Arias JL. 2013. Biocompatible gemcitabine-based nanomedicine engineered by flow focusing for efficient antitumor activity. Int J Pharm. 443:103–109.
   PubMed Web of Science ®Google Scholar
• Mittal A, Gajbe V, Mittal J. 2008. Removal and recovery of hazardous triphenylmethane dye, Methyl Violet through adsorption over granulated waste materials. J. Hazard. Mater. 150:364–375.
   PubMed Web of Science ®Google Scholar
• Nahar M, Mishra D, Dubey V, Jain NK. 2008. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine. 4:252–261.
   PubMed Web of Science ®Google Scholar
• Ofokansi K, Winter G, Fricker G, Coester C. 2010. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery. Eur. J. Pharm. Biopharm. 76:1–9.
   PubMed Web of Science ®Google Scholar
• Oppenheim RC. 1981. Solid colloidal drug delivery systems: nanoparticles. Int J Pharm. 8:217–234.
   Web of Science ®Google Scholar
• Singh R, Lillard JW. 2009. Nanoparticle-based targeted drug delivery Exp. Mol. Pathol. 86:215–223.
   Google Scholar
• Tomlinson E, Davis S. 1986. Site Spesific Drug Delivery. Chichester: Wiley, New York: Plenum press, p. 93.
   Google Scholar
• Yılmaz H, Hamarat Sanlıer S. 2013. Preparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent Artif. Cells Nanomed. Biotechnol. 41:69–77.
   PubMed Web of Science ®Google Scholar
• Zwiorek K, Bourquin C, Battiany J, Winter G, Endres S, Hartmann G, Coester C. 2008. Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides. Pharm Res. 25:551–562.
   PubMed Web of Science ®Google Scholar